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Abstract Formaldehyde is a ubiquitous indoor air pol-
lutant that is classiﬁed as ‘‘Carcinogenic to humans
(Group 1)’’ (IARC, Formaldehyde, 2-butoxyethanol and
1-tert-butoxypropanol-2-ol. IARC monographs on the
evaluation of carcinogenic risks to humans, vol 88. World
Health Organization, Lyon, pp 39–325, 2006). For nasal
cancer in rats, the exposure–response relationship is highly
non-linear, supporting a no-observed-adverse-effect level
(NOAEL) that allows setting a guideline value. Epidemi-
ological studies reported no increased incidence of naso-
pharyngeal cancer in humans below a mean level of 1 ppm
and peak levels below 4 ppm, consistent with results from
rat studies. Rat studies indicate that cytotoxicity-induced
cell proliferation (NOAEL at 1 ppm) is a key mechanism
in development of nasal cancer. However, the linear unit
risk approach that is based on conservative (‘‘worst-case’’)
considerations is also used for risk characterization of
formaldehyde exposures. Lymphohematopoietic malig-
nancies are not observed consistently in animal studies and
if caused by formaldehyde in humans, they are high-dose
phenomenons with non-linear exposure–response relation-
ships. Apparently, these diseases are not reported in epi-
demiological studies at peak exposures below 2 ppm and
average exposures below 0.5 ppm. At the similar airborne
exposure levels in rodents, the nasal cancer effect is much
more prominent than lymphohematopoietic malignancies.
Thus, prevention of nasal cancer is considered to prevent
lymphohematopoietic malignancies. Departing from the rat
studies, the guideline value of the WHO (Air quality
guidelines for Europe, 2nd edn. World Health Organization,
Regional Ofﬁce for Europe, Copenhagen, pp 87–91, 2000),
0.08 ppm (0.1 mg m
-3) formaldehyde, is considered
preventive of carcinogenic effects in compliance with
epidemiological ﬁndings.
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Abbreviations
CI Conﬁdence interval
DPX DNA–protein crosslink(s)
FA Formaldehyde
GSH Glutathione
GLP Good laboratory practice
MN Micronucleus/micronuclei
ICD International classiﬁcation of diseases
NALT Nasopharyngeal-associated lymphoid tissue
NOAEL No-observed-adverse-effect level
RR Relative risk
PMR Proportional mortality ratio
SCC Squamous cell carcinoma
SCE Sister-chromatid exchange
SMR Standardized mortality ratio
TWA Time-weighted average
UR Unit risk
Introduction
As a natural compound, formaldehyde (FA) occurs in
unpolluted ambient air at concentrations usually below
1 lgm
-3; 1 ppb is equal to 1.23 lgm
-3 at 1 atmosphere
and 25 C. In urban environments, concentrations are
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DOI 10.1007/s00204-010-0549-1usually in the range of 1–20 lgm
-3, but may be in areas
with heavy trafﬁc up to 100 lgm
-3 (IARC 2006).
Formaldehyde is a ubiquitous pollutant in indoor air with
a mean global concentration range of 4 to [600 lgm
-3
where reported concentrations varied greatly across coun-
tries (IARC 2006). In Canada, the median indoor air level
was about 30 lgm
-3 with the upper 90th percentile about
60–70 lgm
-3 (Liteplo and Meek 2003). The indoor air
exposures innon-manufacturing ofﬁces or schools in the US
varied from 5 to 80 lgm
-3, estimated from Dodson et al.
(2007). The indoor air concentrations of FA were investi-
gated in eight cities in different European countries; the
mean concentrations varied from 14 to 31 lgm
-3 (de
Bruin et al. 2008). In a comparative study of Uppsala/
Sweden and Nagoya/Japan, the mean indoor air FA level
was 8.3 lgm
-3 (maximum: 19 lgm
-3) and 17.6 lgm
-3
(maximum: 73 lgm
-3), respectively (Sakai et al. 2004). In
German residences, a survey from 2003 to 2006 showed
that the median FA concentration was 24 lgm
-3 and the
95th percentile 48 lgm
-3 (Salthammer et al. 2010).
Formaldehyde is a known nasal carcinogen in rats and
considered a human carcinogen (IARC 2006). The evalu-
ation of carcinogenic risks due to FA in indoor air is based
on two mutually incompatible approaches. The unit risk
(UR) approach assumes a non-threshold approach with
low-dose linear extrapolation and the threshold approach
which assumes an exposure below where no cancer risk
exists. In the allocation of resources to prevent low dose
FA levels, the two approaches predict tremendous differ-
ences in pay back. This study evaluates the recent literature
relevant for risk assessment of low-dose exposure effects
with the purpose to propose a health-based indoor air
guideline for prevention of cancer due to indoor air FA
exposures.
Recently, FA was re-evaluated for carcinogenic effects
and reclassiﬁed as ‘‘Carcinogenic to humans (Group 1)’’
(IARC 2006). In addition to sufﬁcient evidence in animal
studies for nasal carcinogenicity of FA, the IARC con-
cluded that there is sufﬁcient epidemiological evidence that
FA causes nasopharyngeal cancer in humans. This was
based on results from the US National Cancer Institute
(NCI) cohort and supported by the primarily positive
ﬁndings in other studies. Recently, the IARC accepted that
there is sufﬁcient evidence for FA inducing leukemia,
particularly myeloid leukemia (Baan et al. 2009), which
was further supported by a recent study of embalmers
(Hauptmann et al. 2009) and by chromosomal aberrations
in myeloid progenitor cells (Baan et al. 2009) in a small
group of FA-exposed Chinese workers (Zhang et al. 2010).
The IARC (2006) found only limited epidemiological
evidence that FA causes sinonasal cancer in humans and
the overall balance of epidemiological evidence did not
support a causal role for FA-induced cancer at other sites,
including the oral cavity, oro- and hypopharynx, pancreas,
larynx, lung and brain.
Formaldehyde is genotoxic in multiple in vitro models
and in exposed humans and laboratory animals (IARC
2006; SCOEL 2008). Genotoxicity and cytotoxicity are
considered to play important roles in the carcinogenesis of
FA in nasal tissues (IARC 2006) in which cell proliferation
due to cytotoxicity is considered to be a key element in the
development of upper airway cancer (McGregor et al.
2006; SCOEL 2008). For this type of carcinogenic effects,
the no-observed-adverse-effect level (NOAEL) and the use
of assessment factors are considered appropriate for setting
standards or guidelines for airborne exposures (Nielsen and
Øvrebø 2008). The NOAEL approach has been used for
setting health-based occupational exposure limits for FA,
for example, in Europe (SCOEL 2008), Germany (DFG
2009), USA. (ACGIH 2007) and Japan (Omae 2007).
Furthermore, the approach has been used for setting an
outdoor air standard as well as an indoor air guideline in
Germany (Appel et al. 2006; Empfehlung des Umwelt-
bundesamtes 2006; Salthammer et al. 2010), and proposed
for setting an outdoor standard by Japanese scientists
(Naya and Nakanishi 2005). The World Health Organiza-
tion has proposed an air quality guideline of 0.08 ppm
(0.1 mg m
-3) (WHO 2000) for prevention of eye and
airway irritation, and nasal cancer.
The UR, which is based on a non-threshold concept, has
also been applied for risk characterization of FA exposures
(e.g. Wu et al. 2003; Sax et al. 2006; Azuma et al. 2007;
Dodson et al. 2007; Loh et al. 2007). In this case, it is
assumed that the cancer risk of a compound is linearly
related to the exposure in the low-dose range. The UR is
the estimated lifetime risk at lifelong exposure to 1 lgm
-3
of the compound. The UR is calculated from non-threshold
mathematical functions assuming that these apply outside
the range of experimental observations to yield estimates of
risks at the lower doses (e.g. Cal EPA 2005). For example,
the UR has been estimated to 1.3 9 10
-5 (IRIS 1991) and
6 9 10
-6 (Cal EPA 2005).
Methods
Studies published in English in peer-reviewed journals are
considered; the literature search strategies are indicated in
the ‘‘Appendix’’.
We have attempted to avoid interpretation of non-sig-
niﬁcant statistical trends as they may be due either to lack
of statistical power or due to spurious associations, which
cannot be distinguished scientiﬁcally. However, this is not
always possible in the epidemiological studies. Epidemio-
logical studies with multiple exposure relationships and
thus many statistical tests are especially prone to spurious
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123associations. Additionally, false-positive results due to
unadjusted confounder effects may occur. Therefore, haz-
ard identiﬁcation from epidemiological studies has been
performed from meta-analyses to maximize consistency
across studies. The exposure-dependent effects in epide-
miological studies are based on the three largest cohort
studies as their exposure assessments were based on mea-
sured FA concentrations.
Biological mechanisms
Chronic exposure to C6 ppm FA caused exposure-depen-
dent neoplasia of the nasal epithelium, mainly squamous
cell carcinomas (SCC) in rats with a non-linear concen-
tration–response relationship (Table 1). The NOAEL for
development of SCC was 2 ppm (Monticello et al. 1996)a s
also suggested from Table 1, showing the frequency of
detected SCC. Overall, animal data also suggest that organs
which are not in direct contact with FA do not develop
neoplasms, presumably due to the fact that FA is highly
reactive and rapidly metabolized locally (Bosetti et al.
2008; Heck and Casanova 2004; McGregor et al. 2006).
In the nasal tissue, FA reacts with glutathione (GSH)
and forms S-hydroxymethyl-GSH, which is oxidized by the
FA-dependent alcohol dehydrogenase. This results in the
production of formate (IARC 2006; McGregor et al. 2006).
In rats, half saturation of the enzyme is estimated to occur
at 2.6 ppm FA (Casanova et al. 1989) and, thus, higher
exposure levels cause a disproportionate increase in cel-
lular levels of FA (Casanova et al. 1989). As FA is highly
reactive, it can cross-link DNA and proteins in cells, which
is considered the primary genotoxic effect of FA (Liu et al.
2006; Schmid and Speit 2007). The formation of DNA–
protein cross-links (DPX) in nasal tissue shows a biphasic
concentration–response relationship (Casanova et al. 1989,
1994). A conspicuous increase in DPX formation occurs
above 2–3 ppm (Casanova et al. 1989, 1994), where car-
cinogenic effect has been observed in rats (Table 1). The
formation of DPX may be linearly related to the FA con-
centration at or below 0.7 ppm (Casanova et al. 1989,
1994). In vivo studies showed that DPX was not accumu-
lated over repeated exposures in rat nasal tissue (Casanova
et al. 1994). At a similar exposure level, the DPX level was
an order of magnitude higher in rats than in the nasal
mucosa in monkeys, and monkeys are considered to have a
higher DPX level than humans (Casanova et al. 1991; Heck
and Casanova 2004). In consequence, no assessment factor
is needed for extrapolation from rats to humans, which has
been used in the risk characterization.
The development of SCC is considered to be related to a
genotoxic effect caused by DPX (Merk and Speit 1998;
Appel et al. 2006; McGregor et al. 2006) in addition to
cytolethality-regenerative cellular proliferation (Conolly
et al. 2003; McGregor et al. 2006). Increase in the cell
proliferation in the rat nose is considered to occur at about
Table 1 Nasal epithelial squamous cell carcinomas (SCCs) in male (M) and female (F) rats at long-term inhalation exposures to formaldehyde
Concentration range
a (ppm) 1
b 2
c 3
d 4
e 5
f
M (%) F (%) M (%) M (%) M (%) M (%)
0 0/118 (0) 0/114 (0) 0/99 (0) 0/90 (0) 0/26 (0) 0/32 (0)
0.1 – – – – 1/26 (3.8) –
0.3 – – – – – 0/32 (0)
0.7 – – – 0/90 (0) – –
1 – – – – 1/28 (3.6) –
2 0/118 (0) 0/118 (0) – 0/96 (0) – 0/32 (0)
6 1/119 (0.8) 1/116 (0.9) – 1/90 (1.1) – –
10 – – – 20/90 (22) 1/26 (3.8) –
14 51/117 (44) 52/115 (45) – – – –
15 – – 38/99 (38) 69/147 (47) – 13/32 (41)
a For exact concentrations, see the other footnotes
b Exposures were to 0, 2.0, 5.6 or 14.3 ppm, 6 h day
-1, 5 days week
-1 for 24 months in Fischer 344 rats which was followed by 6 months of
non-exposure (Kerns et al. 1983). The numerator is the number of animals with SCC and the denominator is the number of nasal cavities
evaluated. The percentage is given in parenthesis
c Exposures were to 0 or 14.8 ppm lifetime, 6 h day
-1, 5 days week
-1 in Sprague–Dawley rats (Sellakumar et al. 1985)
d Exposures were to 0, 0.69, 2.05, 6.01, 9.93 or 14.96 ppm, 6 h day
-1, 5 days week
-1 for 24 months in Fischer 344 rats (Monticello et al. 1996)
e Exposures were to 0, 0.1, 1 or 9.8 ppm, 6 h day
-1, 5 days week
-1 for 28 months in Wistar rats (Woutersen et al. 1989). This study did not
show an exposure-dependent development of SCC, for further discussion, see the text
f Fisher 344 rats were exposed 6 h day
-1, 5 days week
-1 for 28 months to 0, 0.30, 2.17 or 14.85 ppm (Kamata et al. 1997)
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1232 ppm FA and above (Arts et al. 2006;I A R C2006;
McGregor et al. 2006).
The lack of distant effects of FA is supported by two
observations. First, FA is an endogenous metabolite with a
blood level of about 2–3 mg kg
-1 (IARC 2006). Second,
inhalation does not increase the blood FA level. For
example, exposure of humans to 1.9 ppm for 40 min and
rats to 14.4 ppm for 2 h did not increase blood FA levels
(Heck and Casanova 2004). Also, exposures of monkeys to
6 ppm, 6 h day
-1, 5 days week
-1 for 4 weeks did not
increase the blood FA levels (Casanova et al. 1988). A
simpliﬁed calculation may be used to illustrate that the
delivered FA by inhalation is negligible compared with
the entire body pool. Thus, assuming 100% deposition in
the airways of inhaled FA ([95% is predicted to be
retained (IARC 2006)), a 93% metabolism (Heck and
Casanova 2004), an inhalation of 20 m
3 day
-1 in a 70-kg
man, and an exposure concentration of 0.1 ppm
(0.12 mg m
-3), then the delivered dose to the body pool
would be 0.168 mg day
-1. The delivered amount to the
entire body pool corresponds to about 0.1% of the pool if it
is assumed that the concentration in the blood compartment
(about 2–3 mg kg
-1 (IARC 2006)) is equal to the con-
centration in the entire body (*175 mg = 2.5 mg kg
-1 9
70 kg). The contribution to the body pool neglects that FA
is metabolized rapidly in the blood compartment as the
half-life in rat plasma is about 1 min (McGregor et al.
2006). Also and more important, a toxicokinetic model
predicted that FA is metabolised rapidly by nasal tissue and
does not signiﬁcantly increase the FA blood concentration
(Franks 2005).
Implications of DNA–protein cross-links
DNA–protein cross-links can be induced by several agents,
e.g. ultraviolet light, ionizing radiation, chromium, nickel
and arsenic compounds as well as cisplatin, melphalan,
mitomycin C and aldehydes. DPX are considered to affect
replication, transcription and repair processes. They may
result in mutagenesis or carcinogenesis (Barker et al.
2005), which are well established for FA (IARC 2006).
DPX induced by different chemicals have different chem-
ical stability and ability to be repaired (Barker et al. 2005).
Thus, when FA reaches the nuclear DNA, it forms DPX.
Incomplete repair of FA-induced DPX can lead to the
formation of mutations, in particular chromosome muta-
tions and micronuclei (MN) in proliferating cells (Speit and
Schmid 2006).
Repair of DPX cross-links
In vivo rat studies, FA induced DPX was removed rapidly
in nasal tissue. This means that the DPX produced in any
single day’s exposure should be completely or almost
completely removed by the time of the next day’s exposure
(Casanova et al. 1994). In accordance with this, the risk
assessment model by Conolly et al. (2004) used a half-life
of the DPX repair of 2 h (Subramaniam et al. 2007). In a
recent in vitro study, primary human nasal epithelial cells
were treated with FA for 1 h, which increased the DPX
level. After cessation of the FA exposure, DPX decreased
and the level was no longer signiﬁcantly increased after 8 h
and the DPX was completely removed after 24 h (Speit
et al. 2008). This also supports that no DPX accumulation
(increasing DPX over time) occurs in vivo at the portal-of-
entry epithelial cells. Loss of DPX is considered to be due
to spontaneous hydrolysis and active repair processes
(Quievryn and Zhitkovich 2000).
Chromosomal effects in nasal and buccal cells
The primary genotoxic effect of FA is considered to be
DPX formation (Liu et al. 2006; Schmid and Speit 2007).
In the same concentration range, FA induced chromosome
mutations, sister-chromatid exchanges (SCE) and forma-
tion of MN in V79 Chinese hamster cells, but no gene
mutation was observed in the HPRT locus (Merk and Speit
1998). Both SCE and MN increased non-linearly with
increasing FA level (Merk and Speit 1998) and both
showed an apparent NOAEL in the low-exposure range
(Merk and Speit 1998; Fig. 5).
Genotoxic effects are considered plausible in nasal and
buccal mucosa cells due to the high reactivity of FA. It
appears that the most sensitive genetic endpoints for
detection of FA mutagenicity are chromosomal aberrations
and MN (Speit and Schmid 2006).
A critical review identiﬁed eight human studies,
reporting frequencies of MN in nasal and buccal mucosa
cells. Two studies, (Kitaeva et al. 1996; Ying et al. 1997),
were not considered reliable for methodological reasons
(Speit and Schmid 2006). The remaining six studies were
inconsistent and had limitations in design, exposure char-
acterization and confounder control (Speit and Schmid
2006). One of the studies showed no increase in MN in the
nasal mucosa; the buccal cell effect was not determined. A
study in a plywood factory showed an increase in MN in
nasal cells; buccal cell effect was not determined. We note
that wood dust is a potential confounder. Two studies
determined both nasal and buccal effects. These studies
were from the same embalming course and both showed
buccal, but no nasal effect (Suruda et al. 1993; Titenko-
Holland et al. 1996).
The Suruda et al. (1993) study is selected as represen-
tative as it was the primary study where data was collected.
It is a prospective study with 29 mortician students attend-
ing an 85-day course in embalming, where exposures were
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123to embalming solutions with several volatile compounds,
including FA, glutaraldehyde and phenol. Glutaraldehyde
exposures were below 0.15 ppm and phenol exposures
below 0.1 ppm. Each embalming session lasted about 2 h,
and the mean FA exposure level was 1.4 ppm (range:
0.15–4.3 ppm) with peak exposures up to 6.6 ppm. The
mean 8-h time-weight average FA level was 0.33 ppm on
days where embalmings were made. Several of the students
had part-time jobs in funeral homes with mean FA expo-
sures about 1 ppm (range: 0.58–3.32 ppm). During the
course, the mean number of embalmings per student were
6.9 (range: 2–15). After the embalming course, a 12-fold
increase, which was statistically signiﬁcant, was seen in the
buccal cell MN, whereas a non-signiﬁcant increase (22%;
p = 0.26) was seen in the nasal MN (Suruda et al. 1993).
From the other study, the primary mechanism appeared to
be chromosomal breakage (Titenko-Holland et al. 1996).
The Burgaz and co-workers conducted two studies
(Speit and Schmid 2006), which showed an increase in MN
among FA-exposed subjects in pathology and anatomy
laboratories. The ﬁrst study was devoted to nasal cells and
the second study to buccal cells. In the most recent study in
the buccal mucosa cells, the mean exposures were up to
4 ppm FA obtained by stationary sampling (Burgaz et al.
2002). We note that stationary sampling may underestimate
the personal exposure.
Another study was also evaluated by Speit and Schmid
(2006). Three groups of non-smokers, 18 workers in an
FA-producing factory, 16 waiters exposed to FA from
building materials, furniture and environmental tobacco
smoke, and 23 controls (undergraduate students) were
investigated for MN in the nasal mucosa cells. The 8-h
time-weighted average FA level was 1, 0.1 and
0.01 mg m
-3, respectively, with maximum levels of 1.7,
0.3 and 0.015 mg m
-3. The MN formation was signiﬁ-
cantly increased in the workers, but not in the waiters (Ye
et al. 2005).
A recent controlled study, performed under GLP-like
conditions, had FA concentrations that were relevant for
evaluation of indoor air effects (Speit et al. 2007). Twenty-
one volunteers were exposed to 0.15–0.5 ppm FA with
15 min peaks at 0.6 and 1 ppm, respectively. Exposures
were for 4 h day
-1 for 8 days during a 10-day period. No
signiﬁcant increase was detected in the frequency of MN in
exfoliated buccal mucosa cells.
In conclusion, FA is mutagenic in vivo in nasal and
buccal mucosa cells evaluated from MN formation, which
is a sensitive endpoint (Merk and Speit 1998). Neverthe-
less, the interpretation of the studies is difﬁcult due to lack
of consistency across studies, incomplete information on
study design, exposure and confounding factors in general
(Speit and Schmid 2006). Overall, if the observed muta-
genic effects are FA dependent, the data suggest that
effects are at high mean or high peak exposure concen-
trations, and no effect is expected at exposures somewhat
above normal indoor air levels.
Chromosomal effects in peripheral lymphocytes
Portal-of-entry effects on lymphatic tissue cells could be
possible as the upper airways are richly furnished with
lymphatic tissue (Kuper et al. 2003; Pohunek 2004). Thus,
FA effects on the nasopharyngeal lymphoid tissue (NALT)
and the upper respiratory tract draining (superﬁcial cervical
and posterior cervical) lymph nodes were studied in
mice and rats with FA exposures at 0.5, 1, 2, 6, 10 or
15 ppm for 6 h day
-1, 5 days week
-1 for 4 weeks. Expo-
sure-dependent effects were limited to the 15 ppm group in
rats, where NALT showed hyperplasia and germinal cen-
ters were absent in the superﬁcial cervical lymph nodes.
Also, an increased proliferation of the NALT lymphoepi-
thelium was observed (Kuper et al. 2010). It is suggested
on the basis of the lack of effect in mice and effects in rats
were observed only at the highest exposure level that an FA
effect on local lymphatic tissue should be limited to high
exposure levels.
Several human biomonitoring studies have shown
induction of DPX, SCE, chromosome aberrations and MN
in blood cell cultures. FA-induced DPX is considered the
primary DNA lesion (Speit and Merk 2002; Liu et al.
2006; Schmid and Speit 2007), and the mutagenic effect
is due to chromosomal aberration by a clastogenic
mechanism, but not due to point mutations (Speit and
Merk 2002). In human peripheral blood lymphocytes,
DPX has a long half-life due to inefﬁcient repair pro-
cesses and DPX is mainly removed by spontaneous
hydrolysis. The presence of active DNA repair in these
cells may not be biologically important as lymphocytes
are terminally differentiated cells and because there is no
danger of converting DNA lesions into mutations
(Quievryn and Zhitkovich 2000). The DPX formation in
lymphocyte cultures was non-linear and DPX levels at
low FA doses were apparently similar to DPX in the
control lymphocytes not exposed to FA (Liu et al. 2006,
Fig. 1). Low-dose FA-induced DPX was completely
removed before lymphocytes started to replicate. Cyto-
toxic effects occurred in parallel or even preceded SCE
formation. Formation of MN occurred only if cytotoxicity
was present and only at a certain time-window. Both SCE
and MN formation were non-linearly related to FA
exposure and apparently showed NOAEL (Schmid and
Speit 2007; Figs. 4A, 7A). The authors concluded that
systemic genotoxic effects of FA lack plausibility, sup-
ported by the majority of the rat studies (Kligerman et al.
1984; Speit et al. 2009 and references therein) at expo-
sures up to 15 ppm in 4 weeks.
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123Peripheral lymphocyte effects may comprise not only
DPX, but also DNA–DNA crosslinks that may appear at a
slightly lower concentration, and DNA single-stranded
breaks that may occur at an even lower concentration (Liu
et al. 2006). DNA single-stranded breaks are rapidly
repaired such as in Hela cells, where they were repaired
30–40 times faster than DPX as observed from Liu et al.
(2006). The single-stranded breaks may become a double-
stranded break following DNA synthesis, leading to pro-
duction of an acentric fragment which would then be
expressed as an MN within one division cycle (Fenech
1997); this indicates that cytogenetic assays must investi-
gate several genotoxic mechanisms.
In studies of biomarkers of FA effects in humans, DPX
was elevated in FA exposed staff members in hospital
pathology departments, where FA exposures were about
3 ppm during work (Shaham et al. 1996, 1997) or in the
range from 0.04 to 5.6 ppm (Shaham et al. 2003). The ﬁrst
two studies, considered pilot studies (Shaham et al. 2003),
each comprised 12 exposed subjects. The last and most
comprehensive of the studies comprised 186 exposed and
213 unexposed staff members (Shaham et al. 2003), where
exposures were divided into a low (mean: 0.4 ppm (range:
0.04–0.7)) and a high level (2.24 ppm (0.72–5.6)). The
DPX formation was expressed as the fraction of total DNA,
which was 0.14, 0.19 and 0.20 in the controls, the low and
the high exposed group, respectively. Since FA-dependent
DPX is well established to be exposure dependent in vitro
and in other in vivo studies, the absence of exposure-
dependent effects at mean concentrations from 0.4 to
2.24 ppm is inexplicable.
Cytogenetic studies in peripheral lymphocytes in
FA-exposed individuals are listed in Table 2. The studies
are limited to publications in English, although a few
studies in other languages were retrieved but not included.
This is not considered to inﬂuence a generalization as the
majority of all studied and the recent studies are included.
Additionally, if a research group has published more
studies on the same topic only one study is included. It was
apparent from the meta-analyses of cancer hazards that
different occupations with FA exposures had different
associations with malignancies. This may be due to dif-
ferent exposure levels of FA or different exposures to
confounders. Thus, similar types of exposures are divided
in groups (Table 2). Smoking was the only confounder that
was available from most studies.
Most studies suffer from a low number of exposed
individuals and are therefore not considered to be robust.
Workers in the carpet and the plastic ware plants were
exposed to several airborne compounds in addition to FA
(Lazutka et al. 1999). Also, it is questionable whether the
exposure assessment is robust. This study is therefore not
useful for establishing exposure–response relationships.
Only one study (Ye et al. 2005) consisted of a group
(waitresses) with low mean and low peak exposures at
indoor air levels. This group showed no cytogenetic effect,
but due to the short exposures and the low number of
subjects, this study cannot be used for establishing expo-
sure–response relationships. Exposures were high in all
studies that showed cytogenetic effects. Thus, in the
pathology and anatomy laboratories, the mean exposure
range across studies was\0.1 to 6.4 ppm and the range of
the peak exposures was 0.1 to 20 ppm. Students partici-
pating in an anatomy laboratory course had mean expo-
sures in the range from 0.4 to 2.4 ppm. Mortician students
had a mean exposure of about 1.4 ppm during embalming
with peaks up to about 6 ppm. The industrial exposures
were generally below 1 ppm in mean with peaks above
1 ppm. This suggests that high mean exposures and high
peak levels may drive cytogenetic responses if they are
considered to be FA induced. This interpretation has bio-
logical plausibility, because high exposure levels can
overwhelm detoxiﬁcation mechanisms.
Overall, there is a strong contrast between the generally
negative ﬁndings in animal studies and a recent well-con-
ducted in vitro study (Schmid and Speit 2007) compared
with the studies reported in Table 2. This may be due either
to an inappropriate confounder control or to high FA
exposure levels driving the cytogenetic responses. Due to
the serious limitations, the human studies cannot be used to
establish exposure–response relationships. However, the
human studies roughly suggest that mean and peak expo-
sures should be below 1 ppm, which comply with the
NOAEL for nasal pathologic effects in rats. Thus, risk
characterization based on nasal effects in rats is considered
to protect against chromosomal effects in peripheral lym-
phocytes in humans.
Exposure–response relationships for cytotoxicity
and squamous cell carcinoma in airborne exposed rats
ThemucosaleffectinWistarratswasstudiedatexposuresto
0,0.1,1or10 ppmFA,6 h day
-1,5 days week
-1for1 year
(Appelman et al. 1988) and 28 months (Woutersen et al.
1989). No histological effect was apparent at 1 ppm. The
nasal effects of FA were studied in Fischer 344 rats and
Cynomolgus monkeys at 0, 0.19, 1.0 or 3.0 ppm for
22 h day
-1, 7 days week
-1 for 26 weeks (Rusch et al.
1983). In both species, nasal hyperplasia and squamous
metaplasiawere observed at3.0 ppm,whereasnoeffectwas
observed by light and electron microscopy at 1.0 ppm. The
1 ppm level can be considered the NOAEL for cytotoxicity
at continuous exposure to FA. In another study, nasal epi-
thelial effects were observed at 2 ppm in Fischer 344 rats
exposed for 6 h day
-1, 5 days week
-1 for 6–24 months
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123Table 2 Cytogenetic effects in peripheral blood lymphocytes in formaldehyde (FA) exposed individuals
Exposure Number of participants;
exposed (E), controls
(C) and smokers (S)
Exposure in years,
mean (range) or as
indicated.
Exposure in ppm.
Mean (M) (range)
Peak (P) (range)
Statistically signiﬁcant outcome
of FA exposures
Pathology and
anatomy laboratory
a
E: 30 (S: 8)
C: 30 (S: 7)
(matched)
11 (0.5–27) M: 0.44 (0.04–1.58)
P: up to 4.43
Increased MN, SCE and DNA damage
(comet assay)
Pathology and
anatomy laboratory
b
E: 59 (S: 12)
C: 37 (S: 9)
(matched)
13.2 (0.5–34) M (8 h): 0.1 (\0.1–0.7)
P: 2 (0.1–20)
Increased MN from pre to post-shift
due to chromosome loss. No DNA
damage detected
Pathology and
anatomy laboratory
c
E: 90 (S: 31)
C: 52 (S: *24)
15.4 (1–39) M: 0.4 (0.04–0.7)
P: 2.2 (0.7–5.6)
Increase in SCE, but not exposure-
level dependent
Pathology and
anatomy laboratory
d
E: 6 (S:?)
C: 5 (S:?)
(4–11),
2–4 h day
-1,
2–3 days week
-1
M: (0.9–6.4)
P: (8.0–8.9)
No increase in chromosome aberration
and no increase in SCE
Students taking
anatomy laboratory
course
e
E: 23 non-smokers 3 h three times per
week for 8 weeks
M: 0.41 ± 0.24(SD)
P: 1.04
No increase in SCE and no change in
lymphocyte proliferation comparing
pre and post exposures
Students taking
anatomy laboratory
course
f
E: 13 (S: 0)
C: 10–13 (S: 0)
10 h week
-1 for
12 weeks
M: 2.4 Increase in MN, SCE and frequency of
chromosome aberrations
Students taking
anatomy laboratory
course
g
E: 30
C: 30 (matched)
7 h week
-1 for
15 months
M:\1 No increase in chromosomal
aberrations
Students taking
anatomy laboratory
course
h
E: 8 (S: 0) [2 Afternoons/week
for 10 weeks
M: 1.2 ± 0.8 during dissection Before versus after class evaluation:
Increase in SCE
Mortician students
taking embalming
course
i
C: 23 (S:6) 9 weeks M: 1.5 during embalming
P: 4–14
Before versus after course evaluation:
Decreased O
6-alkylguanine DNA
alkyltransferase activity, but not
exposure-dependent
Mortician students
taking embalming
course
j
E: 29 (S: 5) 85-day study period M (8 h): 0.33.
During embalming (2 h):
M: 1.4 (0.15–4.3)
P: 6.6
Before versus after course evaluation:
MN increased, whereas SCE
decreased
Factory with FA
exposure.
E: 18 (S: 0) 8.5 (1–15) M (8 h): 0.8 ± 0.23(SD)
P: 1.4
Increase in SCE
Waitresses
k E: 12 (S: 0) 12 weeks M (8 h): 0.09 ± 0.05
P: 0.24
No increase in SCE
C: 23 students (S: 0) M (8 h): 0.008 ± 0.002
P: 0.012
Carpet plant
Plastic ware plant
l
E: 79 (S: 39)
E: 97 (S: 36)
C: 90 (S: 27)
(0.2–21)
(0.2–25)
M: (*0.24–1.0)
M: (*0.4–0.73)
Both plants showed increased
chromosomal aberrations, but
independent of the exposure length
Paper factory
m E: 20 (S: 6)
C: 20 (S: 13)
14.5 (2–30) Outside the
papermachine * 0.2
P: B3
Where FA was 20–50, masks
and protective clothes were
worn.
Increased incidence of dicentrics or
dicentrics and ring chromosomes.
No increase in SCE.
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123(Kerns et al. 1983). This indicates that the concentration of
FA may be more important for cytotoxicity than the total
daily dose (Rusch et al. 1983) and substantiated from cal-
culation of the daily exposure-doses. The NOAEL level of
1 ppm was independent of the length of the daily exposure
periodsandthusthedailyexposure-doses(1 ppm 9 6 hand
1 ppm 9 22 h, respectively), whereas the slightly higher
2 ppm concentration caused nasal pathological changes
although the daily dose, 2 ppm 9 6 h, was within the dose
range that caused no effect if the exposure level was 1 ppm.
Formaldehyde caused mainly nasal SCC in rats. A small
number of benign tumors (polypoid adenomas) were also
observed (Kerns et al. 1983; Monticello et al. 1996). Rats
were more sensitive to FA-induced nasal neoplasms than
mice (Kerns et al. 1983) and Syrian golden hamsters
(Dalbey 1982). In the exposure range from 6 to 15 ppm,
the time-to-tumor appearance decreased with increasing
exposure concentration (Monticello et al. 1996), i.e. lower
concentrations require longer exposures for development of
tumors. Apparently, the NOAEL for development of SCC
was 2 ppm (Monticello et al. 1996), which is also sug-
gested from Table 1. The table also shows a clear non-
linear relationship between FA exposure and development
of SCC in the rats.
The Woutersen et al. (1989) study did not show an
exposure-dependent development of SCC in Wistar rats,
which were exposed up to 10 ppm FA for 28 months
(Table 1). The few animals with SCC in the different
groups agree with the incidence of SCC in the control
groups from another study by the same group (Feron
et al. 1988). In that study, three unexposed groups of rats
were kept for 117 to 126 weeks and the respective
incidences of SCC were 0/44, 2/45 (4.4%) and 0/45. In
the Woutersen et al. (1989) study, an SCC incidence of
about 4% in an exposed group is within the range of
SCC in non-exposed rats. The used rats may be less
sensitive (Woutersen et al. 1989) than Fischer 344 and
Sprague–Dawley rats (Table 1), which show a positive
response. Nevertheless, the Wistar rats were able to
respond by developing nasal SCC. Nasal damage was
induced by electrocoagulation which initiated repair
processes and wound healing. Where the nasal damage
preceded the FA exposures, many cases of SCC (15/58;
26%) were observed in the 10-ppm group, but no
exposure-dependent effect appeared at lower exposures
as seen from the SCC incidences in the control group
(1/54; 1.9%), the 0.1 ppm group (1/58; 1.7%) and the
1 ppm group (0/56; 0%). These ﬁndings indicate that
damage-induced cell proliferation is a key mechanism in
FA-induced nasal SCC in rats (Woutersen et al. 1989)
and that B1 ppm FA were not able to induce SCC even
with increased cell proliferation.
Table 2 continued
Exposure Number of participants;
exposed (E), controls
(C) and smokers (S)
Exposure in years,
mean (range) or as
indicated.
Exposure in ppm.Mean (M)
(range)Peak (P) (range)
Statistically signiﬁcant outcome
of FA exposures
FA manufacturing
and processing
n
E: 15
C: 15
(matched: age and sex)
(S: ?)
28 (23–35) After 1971) B 1
Before 1971 B 5
Numerically the frequency of aberrant
metaphases was lowest in exposed
workers
a Costa et al. (2008)
b Orsie `re et al. (2006)
c Shaham et al. (2002)
d Thomson et al. (1984)
e Ying et al. (1999)
f He et al. (1998). No details on exposure characterization
g Vasudeva and Anand (1996). No detail on exposure characterization
h Yager et al. (1986)
i Hayes et al. (1997)
j Suruda et al. (1993)
k Ye et al. (2005)
l Lazutka et al. (1999). Approximate area concentrations were from the hygienic control services. Additional exposures were to styrene and
phenol, which were *0.13–1.4 and 0.3 mg m
-3, respectively, in the carpet plant and *4.4–6.2 and 0.5–0.75 mg m
-3, respectively, in the
plastic ware plant
m Bauchinger and Schmid (1985)
n Fleig et al. (1982)
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123The NOAEL (1 ppm) for nasal cytotoxic effects, the
NOAEL (2 ppm) for development of SCC and the impor-
tance of damage-induced cell proliferation have been used
in the risk characterization.
Exposure–response relationships
for lymphohematopoietic malignancies in animals
Drinking water studies
FA was administered in the drinking water in a 2-year
study in Wistar rats (Til et al. 1989). Males were dosed
with 0, 1.2, 15 or 82 mg kg
-1 day
-1 and females with 0,
1.8, 21 or 109 mg kg
-1 day
-1. Each group comprised 50
rats of each gender. Treatment-related pathological effects
were limited to changes in the stomach and the kidney in
both genders in the high-dose group; the kidney effect was
considered secondary to the decreased intake of liquid. The
incidences of tumors did not vary markedly between the
groups. Thus, the number of tumor-bearing rats as well as
the total number of tumors were lower in the high-dose
males than in the control males. Hematological tumors
were limited to generalized histocytic sarcoma in one male
and myeloid leukemia in another male, both in the high-
dose group. Additionally, no lymphoma appeared in the
high-dose group and no exposure-dependent lymphoma
appeared from the study of the axillary lymph nodes and
the small intestine.
In another study (Tobe et al. 1989), FA was adminis-
tered for up to 24 months in Wistar rats. Exposure levels
were 0, 10, 50 or 300 mg kg
-1 day
-1. Each group con-
sisted of 20 rats of each gender. None of the animals sur-
vived 24 months of exposure in the 300 mg kg
-1 day
-1
group and severe lesions were observed in the stomach.
Additionally, serum urea nitrogen increased signiﬁcantly in
both genders, suggesting an effect on the kidney. It was
reported that there was no signiﬁcant difference in any
tumor incidence among the groups.
In a 104-week study (Soffritti et al. 2002), Sprague–
Dawley rats were exposed to 10, 50, 100, 500, 1000 or
1500 mg FA l
-1 drinking water. An additional group was
treated with 15 mg methanol l
-1. The treated groups con-
sisted of 50 males and 50 females. The tap water control
group consisted of 100 males and 100 females. Animals
were observed until they died spontaneously. There was no
difference insurvival inthegroups.However,the numberof
tumor-bearing animals increased signiﬁcantly in the highest
exposure group in males. In females, the incidence of
malignant mammary gland tumors increased signiﬁcantly in
the highest FA-exposed group. In the female control,
methanol, 10, 50, 100, 500, 1000 and 1500 FA l
-1 groups,
the percentage of animals with hemolymphoreticular
neoplasia was 7, 10, 10, 14, 16, 14, 22* and 20%*, respec-
tively. In the males, the percentage was 8, 20, 8, 20, 26**,
24*, 22* and 46%**, respectively. The level of signiﬁcance
was p\0.05 (*) and p\0.01 (**), respectively. The study
hasanumberoflimitations (IARC2006).Thisappliestothe
‘‘pooling’’ of lymphomas and leukemias (‘‘hemolymphore-
ticular neoplasia’’), the lack of reporting of non-neoplastic
lesions, and the absence of information on incidence of
hemolymphoreticulartumorsinthehistoricalcontrols.Also,
the incidence in comparison with the methanol-treated
group was signiﬁcantly increased only in the high-dose
males, but the dose–response relationship was still statisti-
cally signiﬁcant. Additionally, a surprising discrepancy was
observed. In a preliminary report of the study, it was stated
that 79 animals had hemolymphoreticular malignancies,
whereas it was stated in the ﬁnal report that 150 animals had
these malignancies.
Overall, the drinking water studies showed no increase
in lymphohematopoietic malignancies in two well-con-
ducted studies. Where signiﬁcant, the effects were at the
high FA levels and apparently, exposure–response rela-
tionships were non-linear. However, these results were
from a study with severe limitations.
Inhalation studies
Several long-term studies have been conducted in different
species, including hamsters (Dalbey 1982) and rats (Feron
et al. 1988; Woutersen et al. 1989; Monticello et al. 1996).
They do not report lymphohematopoietic malignancies
with FA exposures from 0.1 to 20 ppm. If lymphohemat-
opoietic malignancies were frequently occurring diseases,
their discovery would have been anticipated. If they are
less frequent than nasal cancer after FA exposure, they may
have been considered incidental ﬁndings and not reported.
However, three studies allow the possibility to be
addressed.
In an inhalation study, groups of approximately 120 male
and 120 female Fischer 344 rats and C57BL/6 9 C3HF1
mice were exposed to 0, 2.0, 5.6 or 14.3 ppm FA 6 h day
-1,
5 days week
-1, for 24 months. The exposure period was
followed by up to 6 months of non-exposure. Gross path-
ological examinations were performed on all animals that
died or were sacriﬁced; histopathology was performed on
50 tissues per animal in the control and the high exposed
group. A signiﬁcant increased mortality was observed both
in male and female rats in the high-dose group and in males
in the intermediate group. Survival in female mice was not
affected by FA exposures. Exposed male mice had a slightly
poorer survival,but this was not statistically signiﬁcant. The
signiﬁcant FA-induced lesions were restricted to the nasal
cavity and proximal trachea in both species (Kerns et al.
1983).
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123The slides from the Kerns et al. (1983) study were
re-evaluated by Woutersen (2007) for investigation of
occurrence of lymphohematopoietic malignancies. Addi-
tionally, to take into account that early death due to nasal
cancer may limit the detection of lymphohematopoietic
malignancies, a mortality adjusted trend test was used (the
Peto Mortality-Prevalence test) for evaluation where
exposed groups showed differences in survival. In the rats,
neither at the end of the 24-month exposure period nor in
the 6-month recovery period were there any association
between FA exposure and leukemia in the male and
female rats. At the end of the 24-month exposure period,
lymphoma was rare in male mice. The occurrence was 1,
1, 1, and 0%, respectively, in the 0, 2.0, 5.6 and 14.3 ppm
FA exposure groups. In contrast, the trend was highly
signiﬁcant in the female mice, where the occurrence of
lymphoma was 17, 16, 9 and 29%, respectively. The trend
was no longer signiﬁcant in mice allowed an additional
3-month recovery period, where the occurrence of lym-
phoma was 50, 20, 15 and 45%, respectively. It was
concluded that FA may induce lymphoma in female mice,
which was clearly driven by the incidence in the top-
exposure group. This re-evaluation allows two conclu-
sions. First, leukemia was not observed in Fischer 344 rats
at 24 months of exposure to 14.3 ppm, where a high
incidence of nasal tumors occurred. Secondly, if lym-
phoma may be induced by FA in mice, the occurrence is at
the very high exposure level, where nasal tumors showed a
high incidence in rats.
In another study with 100 Sprague–Dawley rats, the
exposure was 14.8 ppm FA, 6 h day
-1, 5 days week
-1 for
lifelong exposure. Complete necropsy was performed on
each animal. Histological sections were performed from
each lobe of the lung, trachea, larynx, liver, kidney, testes
and other organs, where gross pathology was present.
There was an increased mortality in the FA group com-
pared with the control group. In the FA group, three
malignant lymphomas were observed. In the similar air
control group of 99 rats, two malignant lymphomas were
observed, whereas three were observed in 99 colony con-
trols (Sellakumar et al. 1985).
In a 28-month study, male F-344 rats in groups of 32
were exposed to FA for 6 h day
-1, 5 days week
-1 at 0,
0.3, 2 or 15 ppm. Additionally, a room control group was
included. The number of rats alive at 18 months or later
and thus available for histopathology was 19 (0 ppm), 22,
17, 7 and 16 (room control), respectively. Hematological,
biochemical and pathological examinations were per-
formed. Tissues for histopathology were pituitary, thyroid,
nasal region, trachea, esophagus, stomach, small and large
intestine, prostate gland, urinary bladder, muscle, femur,
sciatic nerve, spinal cord, mesenteric lymph nodes, and any
other gross lesion. Increased mortality was observed at the
highest exposure concentration. No microscopic lesions
were attributed to FA exposures except these in the nasal
cavity. Also, there was no exposure-related abnormal
hematological ﬁnding (Kamata et al. 1997).
Overall, the occurrence of lymphohematopoietic
malignancies in inhalation studies in rats and mice is not
convincing. An indication of such an association was only
seen in female mice at the highest exposure level, which
caused a high incidence of nasal cancer in rats. Also, the
exposure–response relationship seems to be non-linear.
Cancer hazards from recent meta-analyses
Oral cavity and pharynx, sinus and nasal cavity,
and lungs
Bosetti et al. (2008) conducted meta-analyses based on six
cohorts of industrial workers and six professionals
(pathologists, anatomists, and embalmers and funeral
directors). No signiﬁcant excess cancer risk was found in
industrial workers and professionals for all cancers, and for
oral and pharyngeal cancer. The lung cancer risk was not
affected in the industrial workers (relative risk (RR (95%
CI)): 1.06 (0.92–1.23)), whereas the risk was reduced in the
professionals (0.63 (0.47–0.84)). The study concluded that
there was no considerable risk for cancer of the oral cavity
and pharynx, sinus and nasal cavity, and lungs. The IARC
(2006) also concluded that the overall balance of epide-
miological evidence did not support a causal role for FA in
cancer in the oral cavity, oro and hypopharynx and lungs.
Nasopharyngeal cancer
In the meta-analysis, the nasopharyngeal cancer risk was
increased in FA-exposed industrial workers, but this was
not statistically signiﬁcant (RR (95% CI): 1.33 (0.69–
2.56)) (Bosetti et al. 2008). The increase was based on
eight cancers in one study where six cancers were found in
one of ten plants. If the plant with the six cases was
excluded from the meta-analysis, the RR was reduced to
0.49 in the pooled estimate (Bosetti et al. 2008). Further
discussion of the implication of the cluster with the six
deaths in one plant is included in the following paragraphs.
Brain cancer
No excess brain cancer risk was apparent in industrial
workers (0.92 (0.75–1.13)), but in the meta-analysis, the
risk was signiﬁcantly increased in the professionals (1.56
(1.24–1.96)) (Bosetti et al. 2008). The brain cancer risk
was not consistent across the two types of occupation, and
it is not biologically plausible that FA causes brain cancer.
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and is further supported from the recent study in
embalmers (Hauptmann et al. 2009).
Pancreatic cancer
In a meta-analysis, the RR was 0.8 (95% CI: 0.5–1.0) based
on ﬁve populations exposed to FA (Ojaja ¨rvi et al. 2000).
Pancreatic cancer was also addressed in a meta-analysis
which comprised 14 epidemiological studies (Collins et al.
2001). The overall RR was 1.1 (1.0–1.2). The RR in
industrial workers was 0.9 (0.8–1.1), in embalmers 1.3
(1.0–1.6), and in pathologists and anatomists 1.3 (1.0–1.7).
The authors suggested that there was no relationship
between pancreatic cancer and FA exposures. This con-
clusion agrees with the IARC (2006) evaluation.
Leukemia
Leukemia was studied in a meta-analysis comprising 18
epidemiological studies (Collins and Lineker 2004). Het-
erogeneity was observed across studies and differences
between RRs of FA exposures in US (1.2 (1.0–1.4)) and
European workers (0.9 (0.7–1.1)) appeared. Furthermore,
the RRs were different for various types of job: industrial
workers (0.9 (0.8–1.0)), embalmers (1.6 (1.2–2.0), and
pathologists and anatomists (1.4 (1.0–1.9)). This study
concluded that the data does not provide consistent support
for a relationship between FA exposure and leukemia.
In the meta-analysis by Bosetti et al. (2008), a signiﬁ-
cantly decreased risk of lymphatic and hemopoietic cancer
was observed in industrial workers (0.85 (0.74–0.96). In
contrast, the risk was signiﬁcantly increased in profes-
sionals (1.31 (1.16–1.47)), comprising pathologists, anat-
omists and embalmers. No excess in leukemia risk
appeared in industrial workers (0.90 (0.75–1.07)), but the
risk was signiﬁcantly increased (1.39 (1.15–1.68)) in the
professionals. For further discussion, see the following
paragraphs.
A recent meta-analysis evaluated especially myeloid
leukemia from the highest exposure group of each study
(Zhang et al. 2009). Where several RRs were reported in a
study, one RR was selected from each study according to
peak exposure, average exposure intensity, cumulative
exposure and exposure duration. For example, the accepted
study groups were exposed to more than 2 ppm on average,
having peak exposures above 4 ppm or were exposed for
more than 10 years. The meta-analyses by Zhang et al.
(2009), Bosetti et al. (2008) and Collins and Lineker (2004)
have seven common studies where the sums of the
accepted number of leukemia cases were 69, 161 and 197,
respectively. In the analysis by Zhang et al. (2009), the
ﬁxed effect model and the random effect model showed
similar results—in the ﬁxed effect model, the variability of
the results is estimated from within-study variations, while
the random effect model assumes a different underlying
effect for each study, taking into account between-study as
well as within-study variations (Khoshdel et al. 2006). As
the models gave similar results, no heterogeneity was
revealed and results (RR (95% CI); N = number of studies
included) are from the ﬁxed effect model. An increased
risk was observed for all types of cancer combined (1.25
(1.12–1.39); 19), for all leukemia (1.54 (1.24–1.91); 15),
for myeloid leukemia (1.90 (1.41–2.55); 6) and for multiple
myeloma (1.31 (1.02–1.67); 9), but not for Hodgkin lym-
phoma (1.23 (0.67–2.29); 8) and non-Hodgkin lymphoma
(1.08 (0.86–1.35); 11).
The most recent meta-analysis that includes all relevant
cohort and case–control studies published through May
2009 found no increase in leukemias. The meta-analysis
summary RR was 1.05 (95% CI: 0.93–1.20) for cohort
studies and the summary OR was 0.99 (0.71–1.37) for
case–control studies. Further, the study concludes that the
Zhang et al. (2009) analysis is affected by several limita-
tions that may lead to invalidation of the results (Bachand
et al. 2010).
The different results in the meta-analyses are, at least
partly, due to different study populations with different
exposures. None of the analyses establish numeric con-
centration–response relationships, which are mandatory for
setting standards or guidelines (Nielsen and Øvrebø 2008).
However, the increases in leukemia, myeloid leukemia and
multiple myeloma in the Zhang et al. (2009) study were not
consistently observed in the other studies (Collins and
Lineker 2004; Bosetti et al. 2008; Bachand et al. 2010).
This may be explained if accepting that these types of
cancer may appear at high FA levels, but apparently not at
lower FA levels. However, only four studies (Coggon et al.
2003; Hauptmann et al. 2003, 2009; Pinkerton et al. 2004)
evaluated leukemia rates by quantitative exposure levels.
Cancer hazards from occupational cohorts
To obtain concentration–response relationships for FA
exposures based on human experiences, the cancer risk due
to FA exposures is reviewed from the three largest and
recently updated occupational cohorts identiﬁed from the
IARC (2006), the FA documentation for setting a health-
based occupational exposure limit by the Scientiﬁc Com-
mittee on Occupational Exposure Limits (SCOEL 2008),
and a recent review (Bosetti et al. 2008). Additionally, the
recent update of the US National Cancer Institute cohort is
considered (Freeman et al. 2009). The cancer risks from the
three cohorts are shown in Table 3. This table is limited to
anatomical sites that are directly exposed to airborne FA
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Cancer effects are exposure-dependent as shown from
animal studies (Table 1) and thus potential risks may be
characterized more easily from the cohorts with occupa-
tional exposures that are much higher than indoor air
concentrations.
The US National Cancer Institute (NCI) cohort
Nasopharyngeal cancer
The NCI cohort comprised 25,619 workers employed in ten
US FA-producing or using facilities. Workers were
Table 3 Cancer risks from formaldehyde exposures were reviewed on the basis of the three largest and recently updated cohorts
Study NCI cohort
a (\1996–1994) NCI cohort
a
(\1996–2004)
UK cohort (1941–2000)
a US garment worker cohort
(1955–1998)
a
Exposure (ppm) Median average intensity:
0.45 and range: 0.01–4.25.
Exposure to C2 occurred
in 4.7% and 22.6% had
peak exposures at C4
Range: 0.1 to[2 Geometric mean: 0.15 and
geometric standard
deviation 1.90. Range
0.09–0.2. Past exposures
may have been
substantially higher
Risk estimate
b ICD-8
c O/E SMR ICD-8
c O/E SMR ICD-9
c O/E SMR ICD-9
c O/E SMR
All cancers 140–209 1916
d/–
e 0.90*– – 1.07* 140–208 1511/1375.2 1.10* 140–208 608/– 0.89*
Nose and nasal sinuses 160 3/– 1.19 – – – 160 2/2.3 0.87 160 0/0.16 –
Pharynx – – – 146–149.1 15/9.7 1.55 146–149 3/– 0.64
Nasopharynx 147 8
f/– 2.10* 147 1/2 – 147 0/0.96 –
Larynx 161 23/– 0.95 – – – 161 14/13.1 1.07 161 3/– 0.88
Lung 162 641/– 0.97 – – – 162 594/486.8 1.22* 162 147/– 0.98
Bone 170 7/– 1.57 – – – 170 6/3.5 1.73 –
Prostate 185 131/– 0.90 – – – 185 80/99.4 0.80 185 11/– 1.58
Hodgkin’s disease 201 20/– 1.26 201 25/– 1.42 201 6/8.5 0.70 201 2/– 0.55
Non-Hodgkin’s lymphoma 200 44/– 0.61* 200 94/– 0.85 200 31/31.7 0.98 200 5/– 0.85
&202 &202 &202.0
&202.1
&202.8
Multiple myelomas 203 28/– 0.88 203 48/– 0.94 203.0 15/17.5 0.86 –
Leukemia 204–207 65/– 0.85 204–207 116/– 1.02 204–208 31/34.1 0.91 204–208 24/– 1.09
Lymphatic leukemia – – – 204 36/– 1.15 – – – – – –
Myeloid leukemia 205 –/– – 205 44/– 0.90 0.89
g 205 15/– 1.44
Stomach – – – – – – 151 150/114.4 1.31* 151 13/– 0.80
All digestive 150–159 420/– 0.89* – – – – – – 150–159 116/– 0.77*
The US National Cancer Institute (NCI) cohort comprised 25,619 workers employed in ten US formaldehyde producing or using facilities.
Workers were employed prior to 1 January 1966 and were followed-up through 31 December 1994 (Hauptmann et al. 2003; Hauptmann et al.
2004) and recently through 31 December 2004 for lymphohematopoietic malignancies (Freeman et al. 2009). A British (UK) cohort from six
British factories, comprising 14,014 men employed after 1937 and followed-up through December 2000 (Coggon et al. 2003). The US National
Institute for Occupational Safety and Health established a cohort with 11,039 employees in three garment facilities (US garment worker cohort).
The study was updated through 31 December 1998 (Pinkerton et al. 2004)
a Comparison with national death rates
b Standardized mortality ratio (SMR), observed cases (O), expected cases (E), and the ratio (O/E). When the 95% CI does not include 1.00, it is
indicated by * and bold
c International Classiﬁcation of Diseases: 8th revision (ICD-8) and 9th revision (ICD-9)
d In the Hauptmann et al. (2003) study, the number of formaldehyde workers who had died was 1,916 (2-year lag interval) and in the Hauptmann
et al. (2004), the number was 1,723 (15-year lag interval). The lag interval was 2 years in the Freeman et al. (2009) study
e Not indicated
f Hauptmann et al. 2004 (Table 2) report eight nasopharyngeal cancers among formaldehyde exposed workers that were used for the SMR
calculation. Although one subject was misclassiﬁed on the death certiﬁcate, this subject was retained in the SMR calculation since population
reference rates are based on death certiﬁcates. Also, the exact 95% CI was reported to be 0.91–4.14 and thus the SMR value of 2.10 is not
statistically signiﬁcant. The seven cases in the text and in Tables 3–6 of Hauptmann et al. (2004) were used for calculation of relative risks
g Estimated by Cole and Axten (2004) for the high exposed group ([2 ppm)
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123employed prior to 1 January 1966 and were followed-up
through 31 December 1994 and causes of death were
obtained for 8,486 deceased cohort members (Hauptmann
et al. 2003, 2004). The standardized mortality ratio (SMR)
for the different endpoints is shown in Table 3. The SMR
was 2.10 for nasopharyngeal cancer in FA-exposed work-
ers, which is remarkable compared with the other SMRs.
The 95% conﬁdence interval (95% CI: 1.05–4.21) was
above one, but the increase was not statistically signiﬁcant
as the exact 95% CI was from 0.91 to 4.14 (Hauptmann
et al. 2004).
The relative risk of nasopharyngeal cancer was further
evaluated by four metrics: average exposure intensity
(ppm), highest peak exposure (ppm), cumulative exposure
(ppm-year) and duration of exposure (year). In the average
exposure intensity metric and the highest peak exposure
metric, the RR risks were obtained with the unexposed
group as the reference group. In the three average exposure
intensity exposure groups, [0t o\0.5, 0.5 to \1.0 and
C1 ppm, the respective RRs were: not obtainable (0/3,640
death), 0.38 (1/1,405 death) and 1.67 (6/1,450 death).
Apparently, the increased risk was due to exposures to
C1 ppm FA, although the trend was not statistically sig-
niﬁcant. With the peak exposure metric, all exposed deaths
were in the highest peak exposure group (C4 ppm) and the
trend was statistically signiﬁcant. An exposure-dependent
trend was also found in the cumulative exposure metric
(Hauptmann et al. 2004), which was apparently driven by
the highest exposure level. Stratifying into plants, it
appeared that the majority of the cases occurred in one
plant. Signiﬁcant exposure trends were apparent for the
peak exposure, the cumulated exposure and the duration of
exposure metric (Hauptmann et al. 2004). This suggests an
FA exposure-dependent effect at high exposure levels.
The Hauptmann et al. (2004) study evaluated 11
potential confounders, including wood dust, which was not
found to be a confounder; wood dust is a potential risk
factor for nasopharyngeal cancer (Hildesheim et al. 2001;
Chang and Adami 2006). Smoking is another potential
confounder (Vaughan et al. 2000; Chang and Adami 2006),
but as no increase was apparent in smoking-related dis-
eases, smoking was not a likely confounder. Another
potential confounder is Asian diet (c.f. Spano et al. 2003;
Chang and Adami 2006). It may be important that the
FA-associated risk of nasopharyngeal cancer was highest in
subjects also infected with Epstein–Barr virus (EBV)
(Hildesheim et al. 2001; Chang and Adami 2006). An
EBV-encoded RNA signal is present in nearly all naso-
pharyngeal carcinoma cells (Spano et al. 2003; Wei and
Sham 2005). The study did not address this point (Haupt-
mann et al. 2004). Another potentially important con-
founder has recently been discovered. In the recent update
(Freeman et al. 2009), it was found that 1,006 deaths in the
period 1980–1994 were not identiﬁed and included in the
Hauptmann et al. (2003) and Hauptmann et al. (2004)
studies, which were now included in the recent update
(Freeman et al. 2009).
From reanalyses of the (Hauptmann et al. 2004) study, it
was highlighted that six of the ten nasopharyngeal cancer
cases were from one (the Wallingford) plant with all cases
among the FA-exposed workers, whereas four cases were
from the remaining nine plants, which were divided into
two cases in exposed and two in the non-exposed workers
(Tarone and McLaughlin 2005; Marsh and Youk 2005).
The regional rate-based SMR (95% CI) was 10.32 (3.79–
22.47) for FA-exposed workers in the Wallingford plant
and 0.65 (0.08–2.33) in the combined group of FA-exposed
workers from the other nine plants. Thus, the exposure-
dependent effect (Hauptmann et al. 2004, 2005) was driven
by the cases in the Wallingford plant (Marsh and Youk
2005). Assuming a causal relationship and that the Wal-
lingford plant had a high FA level, it follows that an FA
level exists where no excess nasopharyngeal cancer is
observed.
Later, a follow-up study (1945–2003) was conducted in
the Wallingford plant, including 7,345 workers and seven
(one new) nasopharyngeal cancers (Marsh et al. 2007a).
The local county rate-based SMR for nasopharyngeal
cancer was 4.43 (1.78–9.13). In their nested case–control
study, the nasopharyngeal cancer risk was signiﬁcantly
associated with silver smithing and silver smithing or other
metal work. Neither was a signiﬁcant excess risk nor was a
signiﬁcant trend observed for FA exposure (exposure ver-
sus no exposure), duration of exposure, cumulative or
average intensity. Further, four of seven cases worked
\1 year in the Wallingford plant (c.f. Marsh et al. 2007a).
Overall, excess nasopharyngeal cancers were considered to
be due to metal work and its associated exposures to car-
cinogenic agents, including strong inorganic-acid mists.
However, a limitation of the hypothesis is the lack of
objective exposure data for these potential exposures.
Additionally, a few cases of nasopharyngeal cancers in the
reference group may cause unstable RR estimates (Marsh
et al. 2007b), which applies to the NCI study in the average
exposure intensity and the peak exposure analysis, where
each reference group contained two nasopharyngeal can-
cers. A similar limitation should apply to the Marsh et al.
(2007a) study as the reference groups in several cases have
a small number of cases.
An FA-induced development of nasopharyngeal carci-
noma in the Hauptmann et al. (2004) study is consistent
with the FA-induced development of nasal tumors in rats
(Table 1). Epidemiological studies are less clear and show,
for example, a signiﬁcant association (Vaughan et al.
2000), weaker and occasionally signiﬁcant associations
(Hildesheim et al. 2001), and non-signiﬁcant excesses
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ryngeal cancer in FA-exposed persons. The two other
cohorts (Table 3) showed no increase in nasopharyngeal
cancer. Another potential support for a causal association
in humans is the exposure–response relationship, which
showed a high risk at high exposures and no risk at low
exposures. This corresponds to the non-linear exposure–
response relationship in rats (Table 1) and thus supports the
proposal for a NOAEL.
For indoor air guideline setting, it should be taken into
account that no excess nasopharyngeal cancer was
observed at a mean exposure level of FA at or below 1 ppm
and with peak exposures below 4 ppm. This is in agree-
ment with a NOAEL for SCC in rats at 2 ppm and lack of
histopathologic effect at 1 ppm. This similarity is taken
into account in the risk characterization.
Lymphohematopoietic malignancies
The NCI study also evaluated the effect of average inten-
sity and peak exposures for occurrence of lymphohemat-
opoietic malignancies comprising 178 deaths, 17 in
unexposed and 161 in exposed workers. The SMR for
lymphohematopoietic malignancies (ICD-8: 200–209) was
0.62 (95% CI: 0.39–1.00) in unexposed workers and 0.80
(0.69–0.94) in exposed workers (Hauptmann et al. 2003).
The lowest exposed groups were used as reference for
evaluation of RRs. For the average exposure intensity, the
reference group comprised exposures from 0.1 to 0.4 ppm.
The two higher exposure groups comprised exposures from
0.5 to 0.9 and C1 ppm. Lymphohematopoietic malignan-
cies were signiﬁcantly increased in both groups with a
borderline signiﬁcant trend. Hodgkin’s disease was sig-
niﬁcantly increased in the 0.5–0.9 ppm group with a sig-
niﬁcant exposure-dependent trend. Myeloid leukemia was
signiﬁcantly increased at the highest exposure level, but the
trend was not signiﬁcant. For the peak exposure, the
exposure in the reference group ranged from 0.1 to
1.9 ppm and the exposure in the two higher exposure
groups was 2.0–3.9 and C4 ppm, respectively. Signiﬁ-
cantly increased RRs were observed for lymphohemato-
poietic malignancies and leukemia in the two highest
exposure groups. In the highest exposure group, the RR
risk for myeloid leukemia was also increased. For these
three diseases, the trend in exposure-dependent effect was
statistically signiﬁcant. Additionally, the exposure-depen-
dent trend was statistically signiﬁcant for Hodgkin’s dis-
ease. The RR for leukemia was not associated with
cumulative exposure.
The Hauptmann et al. (2003) study was reanalyzed by
Marsh and Youk (2004). It was shown that excess leukemia
and myeloid leukemia were strongly inﬂuenced by deﬁcits
in death in the reference groups when compared to the US
and local county rate-based SMRs. Using the US and local
county rate-based SMRs, the SMRs for all leukemia and
myeloid leukemia were very close to unity with peak
exposures in the range 2.0–3.9 ppm and not signiﬁcantly
increased in the highest peak exposure category (C4 ppm).
For evaluation of robustness of the categorizations, new
average exposure intensity categories were constructed,
where the highest exposure category comprised
C0.74 ppm. Again, the use of the US and local county rates
showed that the SMRs for all leukemia and myeloid leu-
kemia were close to unity and were not signiﬁcantly
increased. Also in this case, cumulative FA exposures were
not associated with the development of leukemia and
myeloid leukemia.
Recently, the NCI study updated lymphohematopoietic
risks through 31 December 2004 (Freeman et al. 2009).
SMRs were estimated from the US mortality rate (Table 3).
For lymphohematopoietic malignancies, the 319 deaths
resulted in similar SMRs in exposed and unexposed
workers (SMR: 0.94 (95% CI: 0.84–1.06) and 0.86 (0.61–
1.21), respectively). Exposure-dependent trends were
evaluated from exposure categories similar to the previous
follow-up. For lymphohematopoietic malignancies in the
average FA intensity metric, neither of the two highest
exposure groups showed an increased RR and nor was the
exposure-trend statistically signiﬁcant. This is in direct
contrast to the results from the previous follow-up
(Hauptmann et al. 2003). In the new follow-up, the RR for
Hodgkin’s disease was signiﬁcantly increased in the 0.5–
0.9 ppm group, but not in the highest exposure group
(C1 ppm); the trend was statistically signiﬁcant. Similar
results appeared in the previous follow-up. Multiple mye-
loma was signiﬁcantly increased among the non-exposed,
but not in the exposed groups. In the previous follow-up,
the increase was not signiﬁcant. In the peak exposure
metric, lymphohematopoietic malignancies were increased
signiﬁcantly in the highest exposure group (C4 ppm) and
the trend was signiﬁcant. Apparently, it is driven by the
highest exposure group. Thus, the RR in the next highest
exposure group was not remarkably increased (RR (95%
CI): 1.17 (0.86–1.59)), and close to the RR among the
unexposed, which was 1.07 (0.7–1.62). This is in contrast
to the results from the previous follow-up, where the RRs
in the two highest exposure groups were similar (1.71 and
1.87, respectively) and signiﬁcantly increased in both
groups. The trend was also signiﬁcant. In the new follow-
up, the RR of Hodgkin’s lymphoma was increased
signiﬁcantly in the two highest exposure groups (3.30
(1.04–10.50) in the 2.0–3.9 ppm group and 3.96 (1.31–
12.02) in the C4 ppm) with an exposure-dependent trend.
In the previous follow-up, only the trend was increased
signiﬁcantly, but the RRs were approximately of the same
size as in the recent follow-up. Except for a statistical
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other remarkable RR appeared in the peak exposure group
in the new follow-up study. For example, the RRs of mul-
tiple myeloma were 2.74 (1.18–6.37) among the non-
exposed, 1.0 in the reference group ([0–1.9 ppm), 1.65
(0.79–3.61) in the 2.0–3.9 ppm group, and 2.04 (1.01–4.12)
in the highest peak exposure group (C4 ppm) with no
exposure-dependent trend. In this case, the RR risks in the
exposed groups were lower than in the non-exposed group,
which does not support an FA-dependent effect. In the
similar peak exposure groups, the RRs of myeloid leukemia
were 0.82 (0.25–2.67), 1.0, 1.30 (0.58–2.92) and 1.78
(0.87–3.64) with a non-signiﬁcant trend. This ﬁnding is in
strong contrast to the results from the previous follow-up
study, where myeloid leukemia was signiﬁcantly increased
in the highest exposure group (3.46 (1.27–9.43)) with a
highly signiﬁcant trend (p B 0.009), which led to the con-
clusion that FA may cause myeloid leukemia. The authors
of the new follow-up were not able to draw an unequivocal
conclusion regarding the possible link between FA expo-
sures and lymphohematopoietic malignancies. The associ-
ation could be due to chance or be a causal association.
For risk characterization, the only remarkable ﬁnding
from the two follow-up studies is the excess RR of
Hodgkin’s lymphoma. In view of the limited consistency
between the new and the previous follow-up study in
general, the interpretation of the ﬁnding is not clear, as
mentioned by the authors. It is of notice that the RRs
increase abruptly above the exposures in the corresponding
reference group (peak exposure: [0t o\2.0 ppm and
average intensity:[0t o\0.5 ppm), whereas the RR in the
each reference group and the corresponding non-exposed
group was not signiﬁcantly different.
This indicates that an exposure guideline for FA has to
consider that peak exposures should be below 2.0 ppm FA
and average exposures should be below 0.5 ppm FA for
protection against lymphohematopoietic malignancies in
general. This is used in the risk characterization.
The British (UK) cohort
The UK cohort from six British factories comprised 14,014
men employed after 1937 and followed-up through
December 2000 (Coggon et al. 2003). At the end of the
follow-up, 5,185 of the men had died. The overall mortality
from all cancers was slightly higher than expected from
national death rates (SMR: 1.10, 95% CI: 1.04–1.16) as
was the lung cancer (SMR: 1.22, 95% CI: 1.12–1.32) and
the stomach cancer mortality (SMR: 1.31, 95% CI: 1.11–
1.54), c.f. Table 3. Lung and stomach cancers were further
analyzed using the local mortality rates. Lung cancer was
only signiﬁcantly increased (SMR: 1.28, 95% CI: 1.13–
1.44) in the highest exposed group where the FA level was
higher than 2 ppm. No trend was seen at lower levels. For
example, the risk in the 0.6–2 ppm FA range was 0.99
(SMR) with 95% CI from 0.74 to 1.30. However, there was
a non-signiﬁcant decrease in the risk of death from lung
cancer with duration of high exposure. The risk showed no
trend to increase with time since the ﬁrst exposure. The
authors interpreted lung cancer in the highest exposed
group to be ‘‘rather large to be explained simply by a
confounding effect of smoking’’ which was not taken into
account. Using the local mortality rate, stomach cancer was
not exposure-dependent and by the authors considered as a
less plausible outcome. For setting an indoor air guideline,
the key information from this study is that no increase in
lung cancer was apparent at FA levels below 2 ppm. As
this level is above values guiding risk characterization for
nasopharyngeal cancer and lymphohematopoietic malig-
nancies, protection against these diseases is also considered
to protect against a potential lung cancer effect of FA.
The US National Institute for Occupational Safety
and Health (NIOSH) cohort
The US NIOSH established a cohort with 11,039
employees from three garment facilities (The US garment
worker cohort). The study was updated through 31
December 1998 where 2,206 of the employees had died.
The mortality from all malignant neoplasms was signiﬁ-
cantly less than expected (SMR: 0.89, 95% CI: 0.82–0.97),
as was all digestive neoplasms (SMR: 0.77, 95% CI: 0.63–
0.92); see Table 3 for speciﬁc malignancies. Additionally,
subgroup analyses were performed. Myeloid leukemia
(ICD-9: 205) was signiﬁcantly increased (13 death, SMR:
1.91) with 20 or more years since ﬁrst exposure, but the
trend was not signiﬁcant. In addition to underlying cause of
death, all causes listed on the death certiﬁcates were ana-
lyzed using multiple cause mortality. Among workers with
both ten or more years of exposure and 20 years or more
since the ﬁrst exposure, multiple cause mortality from
leukemia was signiﬁcantly increased—almost twofold (15
death, SMR: 1.92, 95% CI: 1.08–3.17). Multiple cause
mortality from myeloid leukemia was also signiﬁcantly
increased among this group (eight death, SMR: 2.55, 95%
CI: 1.10–5.03) (Pinkerton et al. 2004). It is noted that the
mean time weighted average exposure at the plants in the
early 1980s was 0.15 ppm FA but past exposures may have
been substantially higher and mortality from myeloid leu-
kemia was highest among workers ﬁrst exposed in the
earliest years. Confounder control was limited to crude
adjustment for age in the internal analysis. An industrial
hygiene survey conducted at the time of the original study
did not identify any chemical exposure at the plants besides
FA which had likely inﬂuenced the outcome. Smoking was
not reported. On the whole, the study can be used for
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add reliable information on quantitative exposure–response
relationships.
Lymphohematopoietic effects in recent studies
Other studies have suggested an association between FA
exposure and development of lymphohematopietic malig-
nancies (IARC 2006). A proportional mortality study in
embalmers in California that comprised 1,007 white males
who had died, thus showed a mortality signiﬁcantly ele-
vated for total cancer (PMR: 121) and for leukemia (PMR:
175) (Walrath and Fraumeni 1984). In a retrospective
cohort of 2,317 anatomists in the US, the standardized
mortality ration (SMR (95% CI)) was marginally and non-
signiﬁcantly elevated (1.2 (0.7–2.0), which was mainly due
to a non-signiﬁcant increase in leukemia (1.5 (0.7–2.7))
(Stroup et al. 1986). The causes of mortality among 4,046
male US embalmers and funeral directors, who had died,
were investigated in a proportional mortality study. Lym-
phohematopoietic malignancies (PMR: 139), myeloid leu-
kemia (PMR: 157) and other unspeciﬁed leukemia (PMR:
228) were signiﬁcantly increased (Hayes et al. 1990). On
the contrary, in a population-based case–control study in
Iowa and Minnesota that included 513 leukemia cases and
1,087 controls, no association was found between leukemia
and FA exposure. Thus, in the low exposed FA group,
comprising 61 cases, the OR (95% CI) was 1.0 (0.7–1.4)
and 0.7 (0.2–2.6) in the high FA group, comprising three
cases (Blair et al. 2000). The lack of exact exposure con-
centrations is a general limitation of these studies. In
contrast, exposure levels were addressed in the two recent
studies (Zhang et al. 2010; Hauptmann et al. 2009).
Hematopoietic tissue damage was studied in 43 FA
exposed workers, which were compared with 51 controls.
The 8-h time-weighted average was 1.57 and 0.032
mg m
-3, respectively, and the 90 percentile 3.09 and
0.032 mg m
-3, respectively. Peak exposure concentrations
were not reported. FA exposures were associated with
reduced blood lymphocyte, granulocyte, platelet, red blood
cell and total white blood cell counts. For example, the
total white blood cell count was reduced by 13.5% in the
FA-exposed workers. Urinary benzene concentrations were
low in both groups, excluding benzene exposure as a
confounder. The ﬁndings were considered consistent with a
bone marrow toxic effect due to FA (it is noted that it is not
possible to evaluate whether the hematologic parameters
were outside the normal ranges as they were not provided).
Peripheral blood cells from FA exposed and controls were
cultivated to derive blood myeloid progenitor cells. The
colony formation was decreased non-signiﬁcantly by 20%
in the FA exposed workers that was considered a toxic
effect on the myeloid progenitor cells. Blood mononuclear
cells from volunteers were cultivated in vitro to derive
different lines of progenitor cells. Different FA concen-
trations were added to the cultures, showing that FA
decreased the number of generated colonies from all pro-
genitor cell lines. This demonstrated that FA can inhibit the
proliferation of all progenitor cells if the endogenous FA
level is increased due to FA exposures. Blood progenitor
cells of the myeloid line were derived from ten high
exposed workers (8-h time-weighted FA concentration
at 2.63 mg m
-3 and 90 percentile at 5.09 mg m
-3) and
12 controls (8-h time-weighted FA concentration at
0.032 mg m
-3 and 90 percentile at 0.032 mg m
-3).
FA-exposed workers showed increased monosomy (loss) of
chromosome 7 and increase in trisomy of chromosome 8;
these chromosome changes are observed in myeloid leu-
kemia and myelodysplastic syndromes (Zhang et al. 2010).
It is noted that the study has limitations in relation to risk
characterization of FA exposures at indoor air relevant
levels. First, the exposures are extremely high and the
unreported peak exposure concentrations may have been at
extremes. Second, no exposure response relationship was
established. Third, the very high exposure concentrations
may be expected to cause mucosal damage that may
inﬂuence both the nasal metabolism and the absorption into
the blood compartment; no information is available on the
mucosal tissue. Fourth, the in vitro cell culture study is
relevant for mechanistic considerations. However, taking
into account that no increase in FA has been observed in
the blood compartment of humans due to FA exposures
that is supported by model calculations at about 2 ppm
(similar results were reached if using extrapolations up to
10 ppm, but such an extrapolation may not be valid due to
the toxic effects on the mucosal membrane at 2 ppm and
above), the interpretation in relation to risk characterization
is unclear. Fifth, the lowest in vitro tested concentration
(100 lmol FA l
-1) decreased colony formation in human
blood progenitor cells. However, a ﬁve times lower con-
centration (20 lmol FA l
-1) decreased colony formation in
the lung epithelial A549 cell line (Speit et al. 2008), sug-
gesting that the observed effects in progenitor cells reﬂect
cytotoxicity under in vitro cell culture conditions in gen-
eral. Finally, for transparency it would have been desirable
that all measured chemical exposures in addition to FA had
been reported.
In a US case–control study (Hauptmann et al. 2009), 168
professionals employed in the funeral industry who died
from lymphohematopoietic malignancies were compared
with 265 deceased matched controls from the same
industry. The 8-h time-weighted average FA intensity was
about 0.1–0.2 ppm, the average FA intensity while
embalming was about 1.5–1.8 ppm and peak exposures
about 8.1–10.5 ppm. Four cases died from nasopharyngeal
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(0.01–1.2). No increase was observed in lymphoid malig-
nancies (ICD 8 200–204), including Hodgkin lymphoma
(0.5 (0.1–2.6)), which was consistently increased in the
previous industrial cohort studies (Hauptmann et al. 2003;
Freeman et al. 2009). The study observed a speciﬁc asso-
ciation with embalming and myeloid leukemia ((ICD 8
205). Thus, using a reference group of never exposed
individuals containing one myeloid leukemia subject, the
odds ratio (OR (95% CI)) of myeloid leukemia was 11.2
(1.3–95.6) in the FA-exposed individuals.
The ﬁrst analysis of myeloid leukemia used a reference
group of subjects that had not performed embalming. In
this reference group, one subject had myeloid leukemia.
The duration (years (y)) of working in jobs with embalm-
ing showed a signiﬁcant trend (p = 0.02). In the categories
[0–20, [20–34 and [34 years, the odds ratio was 5.0
(0.5–51.6), 12.9 (1.4–117.1) and 13.6 (1.6–119.7), respec-
tively. No signiﬁcant trend was observed with the number
of embalmings. However, several signiﬁcant ORs were
observed. Thus, the number of performed embalmings
were divided into[0–1422,[1422–3068 and[3068 where
the OR was 7.6 (0.8–73.5), 12.7 (1.4–116.7) and 12.7 (1.4–
112.8), respectively. Exposure–response relationships for
the different FA metrics were established. The peak
exposure metric was the only FA metric that showed a
signiﬁcant trend (p = 0.036). Peak FA exposures were
divided into[0–7.0,[7.0–9.3 and[9.3 ppm where the OR
was 15.2 (1.6–141.6), 8.0 (0.9–74.0), 13.0 (1.4–116.9),
respectively. The cumulative FA exposure (ppm-h), aver-
age FA intensity (ppm) while embalming, and the 8-h time-
weighted average intensity (ppm) showed no FA exposure
dependent trend. The cumulative FA exposures (ppm-h)
were divided into [0–4058, [4058–9253, and [9253
where the OR was 10.2 (1.1–95.6), 9.4 (1.0–85.7) and 13.2
(1.5–115.4), respectively. The average FA intensity (ppm)
while embalming was[0–1.4,[1.4–1.9 and[1.9 and the
OR was 11.1 (1.2–106.3), 14.8 (1.6–136.9) and 9.5 (1.1–
86.0), respectively. The 8-h time-weighted FA intensity
(ppm) was divided into [0–0.10, [0.1–0.18 and [0.18
where the OR was 8.4 (0.8–79.3), 13.6 (1.5–125.8) and
12.0 (1.3–107.4), respectively. It is noted that within each
of the FA exposure metrics, the ORs showed little differ-
ence and had highly overlapping conﬁdence intervals. This
suggests that the statistical signiﬁcances are driven mainly
by exposure versus non-exposure and less by differences in
FA exposure levels. Also in each of the FA metrics, none
of the trend tests within the FA groups themselves was
statistically signiﬁcant. Additionally, a few cases in a ref-
erence group have previously been shown to cause unstable
risk estimates (Marsh et al. 2007b).
The second analysis of myeloid leukemia used a refer-
ence group in which the subjects performed fewer than 500
lifetime embalmings. It comprised ﬁve cases with myeloid
leukemia. The duration of working in jobs with embalming
showed a signiﬁcant trend (p = 0.02). In the categories
\20,[20–34 and[34 years, the odds ratios were 0.5 (0.1–
2.9), 3.2 (1.0–10.1) and 3.9 (1.2–12.5), respectively. No
signiﬁcant trend was observed with the number of embal-
mings, but signiﬁcant ORs were observed at the highest
exposure level. Thus, the number of performed embal-
mings were divided into C500–1422, [1422–3068 and
[3068 where the ORs were 1.2 (0.3–5.5), 2.9 (0.9–9.1)
and 3.0 (1.0–9.2), respectively. The peak exposure metric
was the only FA metric that showed a signiﬁcant trend
(p = 0.036) in the FA metrics. Peak FA exposures were
divided into B7.0,[7.0–9.3 and[9.3 ppm where the ORs
were 2.9 (0.9–9.8), 2.0 (0.6–6.6), 2.9 (0.9–9.5), respec-
tively. The trend was not statistically signiﬁcant in the
cumulative FA exposure, the average FA intensity while
embalming or the 8-h time-weighted intensity group. Only
the highest cumulative FA exposure group ([9,253 ppm-h)
had a statistically elevated OR (3.0 (1.0–9.2)). Except for
this, the other ORs were elevated (2.0–2.9) and very similar
within each of the metrics, but none was signiﬁcantly
increased. Also in each of the FA metrics, none of the trend
tests within the FA groups themselves was statistically
signiﬁcant. It is noted that the overall picture was similar to
that in the ﬁrst analysis except for the fact that the ORs
decreased by 1/3 in this analysis, where a larger number of
case subjects were available in the control group. Only one
signiﬁcant OR appeared in the FA exposure metrics, which
was in strong contrast to the ten signiﬁcantly elevated ORs
in the ﬁrst analysis.
It is noted that there is a lack of exposure-dependent
differences in OR within the different FA exposure levels
in the different metrics. A lack of exposure-dependent
effect could be due either to an inappropriate exposure
assessment or to the lack of causality between FA exposure
and myeloid leukemia. The method of FA exposure has
limitations as the estimates were predicted by means of
interviews and mathematical models and were not based on
measured exposures. It is mentioned by the authors that the
peak model was not validated. On the whole, this study
cannot be used for risk assessment as it does not provide a
convincing exposure–response relationship.
The comparison of the Zhang et al. (2010) and the
Hauptmann et al. (2009) studies shows some differences.
The Zhang-study suggests an effect on all progenitor cells
resulting in a decrease in the production of lymphocytes,
granulocytes, platelets and red blood cells. Similar results
were obtained from the in vitro cell cultures with different
progenitor cell lines. In the Hauptmann-study, the effect
was selective at the myeloid progenitor line. Overall, these
studies have very high exposure intensities and thus do
not contradict the conclusion that lymphohematopoietic
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from the Hauptmann et al. (2003) study and its re-analysis
by (Marsh and Youk (2004).
Risk characterization
Lymphohematopoietic malignancies
Lymphohematopoietic malignancies have been reported in
human studies with FA exposures. In contrast, long-term
inhalation carcinogenicity studies in rats, mice or hamsters
were mainly negative or observed as a high-dose phe-
nomenon. This lack of consistency across species (Naya
and Nakanishi 2005; Pyatt et al. 2008) weakens the support
for a causal relationship. From the reanalysis (Marsh and
Youk 2004) of the Hauptmann et al. (2003) study, no
excess lymphohematopoietic malignancies was observed
with a mean exposure level of FA below 0.74 ppm and
peak exposures below 4 ppm. Cross-comparison of results
from the recent follow-up (Freeman et al. 2009) and the
previous follow-up (Hauptmann et al. 2003) showed con-
sistency only for Hodgkin’s lymphoma. However, the
interpretation of the ﬁnding is not clear due to several
different outcomes in the two studies. Nevertheless, if the
ﬁndings are accepted for establishing a guideline value for
FA, peak exposures have to be below 2 ppm and average
exposures below 0.5 ppm. No excess risk was observed for
Hodgkin’s disease, non-Hodgkin’s lymphoma, multiple
myelomas and leukemia in the UK cohort (Coggon et al.
2003), which also has a high exposure level. In contrast, the
US NIOSH cohort showed an increase in leukemia
(Pinkerton et al. 2004), although it had the lowest exposure
level. The overall conclusion from the comparison of the
meta-analyses (Collins and Lineker 2004; Bosetti et al.
2008; Zhang et al. 2009; Bachand et al. 2010) suggests that
the association between FA exposures and the malignan-
cies is limited to the high exposure levels if caused by FA.
The meta-analysis based on the highest exposure levels
reported that FA exposures were associated with occur-
rence of leukemia and especially myeloid leukemia (Zhang
et al. 2009). Three hypotheses were proposed as explana-
tion. First, FA could be transported by the blood to the
bone marrow where it could cause initiation in a stem or
progenitor cell. Second, as a portion of the bone marrow
stem and the progenitor cells circulates in the peripheral
blood, they may be initiated by FA absorbed into the blood.
Third, initiation of the primitive pluripotent stem cells
presented within the nasal mucosa could occur followed by
transport to the bone marrow. These hypotheses were
addressed in comprehensive evaluations (Heck and Casa-
nova 2004; Golden et al. 2006; Pyatt et al. 2008). The ﬁrst
hypothesis is not in accordance with the lack of toxic
effects on the bone marrow (a target organ of known leu-
kemogenic compounds), the negligible increase in blood
FA levels in inhalation studies, and the lack of leukemo-
genic effect in animal studies. The second hypothesis does
not comply with the negligible transport of FA to the blood
and with lack of leukemia in experimental animals. Neither
was a local effect, the third hypothesis, considered likely as
no consistent effect was observed in the numerous animal
studies; humans and animals have the same types of nasal
tissue.
Overall, nasal (portal-of-entry) effects caused by high
FA exposure levels could be a plausible mechanism for
Hodgkin’s disease, but human studies on lymphohemato-
poietic malignancies are inconsistent in general. For risk
characterization of lymphohematopoietic malignancies, it
is considered sufﬁcient that mean exposures are below
0.5 ppm and peak exposures below 2 ppm. The studies
used to derive the values may not express cause–effect
relationships. For risk characterization, it is therefore
accepted that a derived indoor air guideline must be below
these values.
Nasal cancer
In the recent epidemiological studies, nasopharyngeal
cancer was not observed with mean exposure levels below
1 ppm and peak levels below 4 ppm, which is consistent
with studies in animals (Table 1). However, the limited
consistency of the epidemiological studies and the difﬁ-
culty in obtaining consistent exposure–response relation-
ships from the studies led a recent comprehensive review to
conclude that ‘‘human studies fail to raise a convincing
conclusion concerning the carcinogenicity of FA and are
not helpful to delineate a possible dose–response relation-
ship’’ (Duhayon et al. (2008). Therefore, we depart from
the nasal effects in rats for the purpose of proposing a
health-based indoor air guideline value.
Three competitive approaches are used:
• The NOAEL approach is based mainly on the strongly
non-linear relationship between FA exposure and
development of SCC in rats (Table 1) by and large
corroborated by the epidemiological studies. For addi-
tional support, see Table 4. This approach accepts that
the decrease in the carcinogenic effect is so rapid that
the observed NOAEL resembles a true NOAEL that is
substantiated by the steep exposure–response relation-
ship (Table 1). Also, SCC appeared at exposure levels,
where the detoxiﬁcation mechanism had been over-
whelmed as the half-saturation of the enzyme system
was observed at 2.6 ppm FA. At lower exposure levels,
no SCC appeared and free FA is low in the nasal tissue,
substantiated from the lack of tissue damage below
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1231 ppm FA. Additionally, the tissue damage–driven cell
proliferation has experimentally been demonstrated to
play a key role in the development of SCC. Accepting
these arguments, an indoor air guideline value can be
set by dividing the appropriate NOAEL by one or more
assessment factors (Nielsen and Øvrebø 2008). This
approach considers the NOAEL for SCC in rats
(2 ppm) and the NOAEL for nasal cytotoxicity in rats
(1 ppm). From the higher FA-induced DPX formation
in rats compared to monkeys, it appears that no
assessment factor is needed by extrapolation from rats
to humans. The intra human variation has to consider
that the FA-induced nasal cancer is a local effect. Also,
the FA-induced DPX formation in children, often
considered especially sensitive, is estimated to be
lower than in adults. This suggests a limited variation
within the human population. Therefore, the use of a
default factor of ten for intraspecies variation will
greatly overestimate the risk due to variations within
humans. However, if this factor is retained, it results in
a derived indoor air guideline value of 0.1 ppm
(0.123 mg m
-3). This value is below all guidance
values derived from the epidemiological studies, and
thus considered to be protective for all types of cancer,
including lymphohematopoietic malignancies.
• The low-dose linear extrapolation approach is mainly
supported by worst-case assumptions (Table 4). The
approach is based on the theoretical assumption of a
linear relationship between FA exposure and a genetic
damage (e.g. DPX formation) that induces cancer. A
linear relationship between FA exposure and DPX
formation in vivo has been suggested from few points
below exposures, where SCC has been observed in rats
(e.g. Casanova et al. 1989, 1994); a slight but signif-
icant covalent binding of FA to DNA was detected at
0.3 ppm that increased disproportionately at 2 ppm and
higher FA concentrations (Casanova et al. 1989, 1994).
The low-dose linear extrapolation approach disregards
the fact that increased cell proliferation has been
suggested to be a prerequisite for a FA-induced cancer
in animals in addition to the requirement for a certain
FA level, see the animal section. The linear risk
characterization approach should be considered a type
of ‘‘worst-case scenario’’.
• To obtain a deeper knowledge and thus a better risk
characterization, a biological motivated model has been
developed. It models exposures by computational ﬂuid
dynamics and the development of cancer from a two-
stage clonal growth model (WHO 2002; Conolly et al.
2003, 2004). Formaldehyde was assumed to act as a
Table 4 Summary of approaches used in the risk assessment strategies for formaldehyde (FA)
Effect Supporting a NOAEL approach Supporting a linear extrapolation
Repair of DNA–protein
crosslinks
No accumulation of DPX based on rapid in vivo repair in rats Accumulation of DPX based on in vitro
immortalized cell lines
a
DPX formation in
lymphocyte cultures
DPX formation was non-linear and the DPX level in non-exposed cells
was similar to DPX in cells at low FA levels
–
Genotoxic effects in nasal
and buccal mucosa cells
Chromosomal aberrations and MN are considered to be sensitive genetic
endpoints. Both are suggested to show NOAEL at indoor air levels
A NOAEL is not accepted for FA
induced genotoxic effects
Genotoxic effects in
peripheral lymphocytes
In vitro cytogenetic tests suggested NOAEL NOAEL is not accepted for FA induced
genotoxic effects
Development of nasal
tumors
In rats, the exposure–effect relationship was non-linear with an apparent
NOAEL
A linear exposure–response relationship
at low exposures cannot be disproved
statistically
Development of nasal
tumors
In rats, cell proliferation was considered crucial for development of
tumors
Assuming that tumor development may
occur without cytotoxicity induced
increase in cell proliferation
Development of nasal
tumors
In rats, a minimum FA exposure level was necessary even in the case of
cell proliferation
Assuming that all FA exposure levels
increase the risk of development of
tumors
Nasopharyngeal cancer in
humans
The FA-induced effects seem to occur at high exposure levels, especially
high peak levels. An apparent level exists where no increased risk was
observed
Due to a limited number of cases, a low-
level exposure risk cannot be
disproved
Lymphohematopoietic
malignancies in humans
Although limited consistency exists across studies, potential effects seem
to occur at high exposure levels, especially high peak levels. An
apparent level exists where no increased risk was observed
Due to a limited number of cases, a low-
level exposure risk cannot be
disproved
For explanations see text
a Subramaniam et al. (2007)
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123direct mutagen with the effect considered proportional
to the concentration of the pro-mutagenic DPX lesion.
The DPX formation is considered linearly related to the
FA concentration. At high concentrations, the model
includes that cytolethality is followed by increased cell
proliferation. Mutations are considered to occur during
cell division processes and a tumor cell arises when an
initiated cell (modeled by DPX levels) acquires a
second mutation (WHO 2002; Conolly et al. 2003).
Several of the parameters were estimated from the best
ﬁt of the model to the experimental data (Conolly et al.
2003). The biological motivated model was extended to
humans and took into account that humans are oronasal
breathers (WHO 2002; Conolly et al. 2004). For the
general population, the predicted additional risk of
upper respiratory tract cancer for non-smokers, associ-
ated with an 80-year continuous exposure to levels of
0.1 ppm FA was about 2.7 9 10
-8 (WHO 2002). The
additional risk was estimated to be 10
-6 or less in
non-smokers exposed continuously for 0.2 ppm FA
(Conolly et al. 2004).
Subramaniam et al. (2008) identiﬁed key biological and
statistical uncertainties of the Conolly et al. (2003) rat
model and its extension to human exposures. Uncertainties
comprise variability of FA-induced cell replication, sensi-
tivity to the estimates for initiated cell formation and death
rate, and extrapolation of parameters to those in the human
model. Additionally, the use of DPX as a surrogate of
mutagenicity was proposed to underestimate FA induced
cancer. The robustness of the Conolly et al. (2004) esti-
mate was further challenged by sensitivity analyses
(Subramaniam et al. 2007; Crump et al. 2008) and further
discussed (Conolly et al. 2009; Crump et al. 2009). There
were two main outcomes of the analyses, which con-
tradicted the Conolly et al. estimate. First, it is not con-
sidered possible to establish a reliable control group of
non-exposed rats for a rare disease as SCC in rats. This is
necessary for obtaining a reliable risk estimate. Second, it
was not considered possible to obtain reliable parameters
of the model, especially those for the initiated cell.
Sensitive groups
A recent model study showed that FA exposure of children
would result in less DPX formation in the airways than it
would in adults (Firestone et al. 2008). Interhuman vari-
ability in the nasal dosimetry of FA was investigated by
means of computational ﬂuid dynamics models in ﬁve
adults and two children, aged 7 and 8. The simulations
predicted the intrahuman variability to be 1.6-fold among
the individuals. No signiﬁcant differences were noted
between the two age groups (Garcia et al. 2009). In
consequence, children are not expected to be more sensi-
tive to a carcinogenic effect of FA than adults and, thus, are
not considered separately in the further evaluation.
Indoor air guideline level for prevention of cancer
Formaldehyde is a normal component of the blood. In
humans, exposure to about 2 ppm airborne FA did not
increase the blood level and exposure to 0.4 ppm FA did
not increase urinary formate excretion due to a rapid
metabolism (IARC 2006). No signiﬁcant increase in blood
FA levels was predicted in the exposure range from 0.1 to
10 ppm FA in a toxicokinetic model (Franks 2005). In
monkeys, 6 ppm FA, 6 h day
-1, 5 days week
-1 in
4 weeks did not increase the blood FA level. In rats, the
half-time of FA is about 1 min in the plasma after intra-
venous administration (IARC 2006). This suggests that
normal indoor air levels of FA are not expected to increase
internal organ exposures, and indoor air effects of FA are
expected to be limited to effects at the portal-of-entry.
Risk characterization of the carcinogenic effect of FA
exposures has been based on two different approaches;
the bases are summarized in Table 4. The NOAEL
approach accepts the non-linear dose–response relation-
ship apparent from the experimentally accessible part of
the relationship in addition to cytotoxicity as a key
mechanism. Both are experimentally supported. The lin-
ear extrapolation model is supported from more extreme
(‘‘worst-case’’) toxicological parameters, which suggest a
low-dose linear relationship for the carcinogenic effect in
the scientiﬁcally non-accessible part of the exposure–
response curve, which neither can be ruled out nor can be
supported experimentally.
Based on the comparisons of the arguments in Table 4,
we favor the NOAEL approach for risk assessment of
FA-induced nasal effects and the use of one or more
assessment factors (Nielsen and Øvrebø 2008). This
approach reaches the conclusion that 0.1 ppm (0.123
mg m
-3) FA will not give rise to a cancer risk in the
general population. The estimates from the biological
motivated models (WHO 2002; Conolly et al. 2004) sug-
gest a negligible risk for the general population about 0.1 to
0.2 ppm. The two approaches overall reached the same
conclusion. Thus, accepting the previous guideline value of
0.08 ppm (0.1 mg m
-3) set by the WHO (2000), this
introduces an additional margin-of-exposure. In conclu-
sion, the WHO (2000) guideline value is considered
defendable for prevention of all types of cancer, including
lymphohematopoietic malignancies.
Acknowledgments The work was partially carried out in the
framework of the WHO Indoor Air Quality Guideline development
442 Arch Toxicol (2010) 84:423–446
123(2006–2009). Partial support was also obtained from the Centre for
Indoor Climate and Diseases in Dwellings supported ﬁnancially by
Real Dania.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
Appendix
Literature search was in PubMed with search terms
‘‘formaldehyde AND indoor air AND concentration*’’,
‘‘formaldehyde AND DNA–protein crosslink*’’, ‘‘formal-
dehyde AND genotox* AND blood AND lymphocyte*’’,
‘‘lymphatic AND tissue AND nose AND review’’,
‘‘micronucleus AND test AND review’’, ‘‘formaldehyde
AND cancer AND meta-analysis’’, ‘‘formaldehyde AND
cancer AND humans’’, ‘‘‘unit risk’ AND formaldehyde’’,
‘‘Epstein–Barr AND nasopharyngeal cancer AND review’’,
‘‘Hauptmann M AND nasopharyngeal carcinoma’’, ‘‘Hau-
ptmann M AND silver smithing’’, ‘‘silver smithing AND
nasopharyngeal carcinoma’’, ‘‘silver smithing AND can-
cer’’, ‘‘acid AND nasopharyngeal carcinoma AND
review’’, ‘‘nickel AND nasopharyngeal carcinoma’’ ‘‘‘unit
risk AND cancer AND review’’ and ‘‘Zhang L AND
formaldehyde’’. Additionally, references were obtained
from IARC (2006), SCOEL (2008), Bosetti et al. (2008).
Two recent studies were provided by the IARC.
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